We present a model describing the parallel interactions between cypD, 17β-HSD10, and different fragments of Aβ in different oligomerization states, and show that the model allows estimation of the evolution of levels of free biomolecules and their complexes under selected conditions associated with the progression of AD. Here, HSD17B10 is linked to Alzheimer disease.